Published in Biochem Pharmacol on March 02, 1994
Neuroimmune interactions and pain: focus on glial-modulating targets. Curr Opin Investig Drugs (2008) 1.50
Propentofylline-induced astrocyte modulation leads to alterations in glial glutamate promoter activation following spinal nerve transection. Neuroscience (2008) 1.14
Chronic administration of the methylxanthine propentofylline impairs reinstatement to cocaine by a GLT-1-dependent mechanism. Neuropsychopharmacology (2013) 0.91
A cell-based PDE4 assay in 1536-well plate format for high-throughput screening. J Biomol Screen (2008) 0.89
Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL/6J mice. Front Neurosci (2014) 0.88
Regulation of intestinal hPepT1 (SLC15A1) activity by phosphodiesterase inhibitors is via inhibition of NHE3 (SLC9A3). Biochim Biophys Acta (2007) 0.83
Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats. Br J Pharmacol (2010) 0.81
Methylxanthine inhibit fungal chitinases and exhibit antifungal activity. Mycopathologia (2011) 0.79
Neuromodulatory effect of propentofylline on rat brain under acute and long-term hypoperfusion. Br J Pharmacol (2001) 0.79
Influence of pentoxifylline and its derivatives on antibiotic uptake and superoxide generation by human phagocytic cells. Antimicrob Agents Chemother (1995) 0.78
A Cell-based beta-Lactamase Reporter Gene Assay for the CREB Signaling Pathway. Curr Chem Genomics (2009) 0.77
Phosphodiesterase regulation of alcohol drinking in rodents. Alcohol (2015) 0.77
Policy interventions that attract nurses to rural areas: a multicountry discrete choice experiment. Bull World Health Organ (2010) 2.17
Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J (2000) 1.89
Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol (1999) 1.45
Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)- octadecatrienoic acids from alpha-linolenic acid. J Biol Chem (1995) 1.45
A simple and efficient method for platelet isolation from their plasma. Thromb Res (1980) 1.26
Requirement and role of arachidonic acid in the differentiation of pre-adipose cells. Biochem J (1989) 1.25
Blood compartmental metabolism of docosahexaenoic acid (DHA) in humans after ingestion of a single dose of [(13)C]DHA in phosphatidylcholine. J Lipid Res (1999) 1.15
Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes. Free Radic Biol Med (2005) 1.15
The phospholipid and fatty acid composition of human platelet surface and intracellular membranes isolated by high voltage free flow electrophoresis. J Biol Chem (1982) 1.12
13-Hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor, LOX. J Biol Chem (1985) 1.11
Retroconversion and metabolism of [13C]22:6n-3 in humans and rats after intake of a single dose of [13C]22:6n-3-triacylglycerols. Am J Clin Nutr (1996) 1.09
Localisation of phospholipase A2 and diglyceride lipase activities in human platelet intracellular membranes. FEBS Lett (1981) 1.08
Preferential incorporation of sn-2 lysoPC DHA over unesterified DHA in the young rat brain. Am J Physiol (1994) 1.06
Covalent modifications of aminophospholipids by 4-hydroxynonenal. Free Radic Biol Med (1998) 1.05
Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation. Biochem Pharmacol (1999) 1.05
Human plasma albumin transports [13C]docosahexaenoic acid in two lipid forms to blood cells. J Lipid Res (1997) 1.04
The cAMP-specific phosphodiesterase PDE4D3 is regulated by phosphatidic acid binding. Consequences for cAMP signaling pathway and characterization of a phosphatidic acid binding site. J Biol Chem (2000) 1.04
Unsaturated fatty acids esterified in 2-acyl-l-lysophosphatidylcholine bound to albumin are more efficiently taken up by the young rat brain than the unesterified form. J Neurochem (1992) 1.03
Platelets mediate the action of diethylcarbamazine on microfilariae. Nature (1987) 1.02
Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina. Arch Biochem Biophys (1999) 1.01
Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation. FEBS Lett (2009) 1.01
Caspase-dependent ceramide production in Fas- and HLA class I-mediated peripheral T cell apoptosis. J Biol Chem (1998) 1.00
Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus. Thromb Res (1980) 0.99
Covalent binding of 15-deoxy-delta12,14-prostaglandin J2 to PPARgamma. Biochem Biophys Res Commun (2005) 0.98
Hydroxy-alkenals from the peroxidation of n-3 and n-6 fatty acids and urinary metabolites. Prostaglandins Leukot Essent Fatty Acids (2006) 0.95
Thrombocytopenia, macrothrombocytopathia, nephritis and deafness. Am J Med (1976) 0.95
The lipid peroxidation end-product 4-HNE induces COX-2 expression through p38MAPK activation in 3T3-L1 adipose cell. FEBS Lett (2007) 0.95
Selective inhibition of one of the cyclic AMP phosphodiesterases from rat brain by the neurotropic compound rolipram. Biochem Pharmacol (1985) 0.92
Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products. Free Radic Biol Med (1998) 0.92
The topoisomerase inhibitors camptothecin and etoposide induce a CD95-independent apoptosis of activated peripheral lymphocytes. Cell Death Differ (2000) 0.91
Stereospecific inhibition of PGH2-induced platelet aggregation by lipoxygenase products of icosaenoic acids. Biochem Biophys Res Commun (1983) 0.91
Anthracyclines trigger apoptosis of both G0-G1 and cycling peripheral blood lymphocytes and induce massive deletion of mature T and B cells. Cancer Res (2000) 0.91
Protective effect of docosahexaenoic acid against hydrogen peroxide-induced oxidative stress in human lymphocytes. Biochem Pharmacol (1999) 0.91
Docosahexaenoic acid is a major n-3 polyunsaturated fatty acid in bovine retinal microvessels. J Neurochem (1996) 0.90
12-HETE inhibits the binding of PGH2/TXA2 receptor ligands in human platelets. Thromb Res (1991) 0.90
Metabolic fate of an oral tracer dose of [13C]docosahexaenoic acid triglycerides in the rat. Am J Physiol (1996) 0.89
LDL from obese patients with the metabolic syndrome show increased lipid peroxidation and activate platelets. Diabetologia (2011) 0.89
Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid. Thromb Res (1984) 0.89
Role of lipoxygenase products in platelet function: relation to fatty acid modified phospholipids. Adv Exp Med Biol (1985) 0.88
Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents. Mol Pharmacol (1993) 0.88
Aldehydes from n-6 fatty acid peroxidation. Effects on aminophospholipids. Prostaglandins Leukot Essent Fatty Acids (2002) 0.87
Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes. J Mol Cell Cardiol (1996) 0.87
Mitochondrial H2O2 production is reduced with acute and chronic eccentric exercise in rat skeletal muscle. Antioxid Redox Signal (2006) 0.87
Stable isotope tracer and gas-chromatography combustion isotope ratio mass spectrometry to study the in vivo compartmental metabolism of docosahexaenoic acid. Anal Biochem (1994) 0.87
Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status. Thromb Res (1988) 0.86
Involvement of cell-cell interactions in the pathogenesis of diabetic retinopathy. Diabetes Metab (1997) 0.86
The influence of low intake of n-3 fatty acids on platelets in elderly people. Atherosclerosis (1999) 0.86
Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother (2013) 0.86
Gas chromatographic-mass spectrometric measurement of 15-deoxy-delta(12,14)-prostaglandin J(2), the peroxisome proliferator-activated receptor gamma ligand, in urine. Clin Chem (2001) 0.86
DHA metabolism: targeting the brain and lipoxygenation. Mol Neurobiol (2010) 0.86
Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation. Biochem J (1997) 0.86
Involvement of type 4 cAMP-phosphodiesterase in the myogenic differentiation of L6 cells. Mol Biol Cell (1999) 0.86
Functional lipidomics of oxidized products from polyunsaturated fatty acids. Chem Phys Lipids (2011) 0.86
Interactions between prostaglandin precursors during their oxygenation by human platelets. Biochim Biophys Acta (1982) 0.86
Preferential transfer of 2-docosahexaenoyl-1-lysophosphatidylcholine through an in vitro blood-brain barrier over unesterified docosahexaenoic acid. J Neurochem (1999) 0.86
Effect of glycated LDL on microvascular tone in mice: a comparative study with LDL modified in vitro or isolated from diabetic patients. Diabetologia (2003) 0.85
Specific markers of lipid peroxidation issued from n-3 and n-6 fatty acids. Biochem Soc Trans (2004) 0.85
In vitro incorporation and metabolism of icosapentaenoic and docosahexaenoic acids in human platelets--effect on aggregation. Thromb Haemost (1986) 0.85
Leukotriene B4 level in stimulated blood neutrophils and alveolar macrophages from healthy and asthmatic subjects. Effect of beta-2 agonist therapy. Eur J Clin Invest (1992) 0.85
Diacylglycerol lipase activity in human platelet intracellular and surface membranes. Some kinetic properties and fatty acid specificity. FEBS Lett (1985) 0.85
Skeletal muscle microcirculation: the effects of limited blood supply and treatment with torbafylline. Int J Microcirc Clin Exp (1990) 0.85
Hyperglycaemia modifies the reaction of microvessels to insulin in rat skeletal muscle. Diabetologia (1998) 0.84
Early increase in lymphocyte cyclic nucleotide phosphodiesterase activity upon mitogenic activation of human peripheral blood mononuclear cells. J Cell Physiol (1992) 0.84
Albumin antioxidant capacity is modified by methylglyoxal. Diabetes Metab (2005) 0.84
Phosphatidic acid stimulates the rolipram-sensitive cyclic nucleotide phosphodiesterase from rat thymocytes. Biochim Biophys Acta (1993) 0.84
Antibiotics and production of granulocyte-macrophage colony-stimulating factor by human bronchial epithelial cells in vitro. A comparison of cefodizime and ceftriaxone. Arzneimittelforschung (1994) 0.84
Effects of fatty acids on human platelet glutathione peroxidase: possible role of oxidative stress. Biochem Pharmacol (1997) 0.84
The impaired in vitro production of interleukin-2 in HIV infection is negatively correlated to the number of circulating CD4+DR+ T cells and is reversed by allowing T cells to rest in culture: arguments for in vivo CD4+ T cell activation. Clin Immunol Immunopathol (1993) 0.83
Lipoxygenase activity of intact human platelets. Prostaglandins Leukot Med (1984) 0.83
12(S)-Hydroperoxy-eicosatetraenoic acid increases arachidonic acid availability in collagen-primed platelets. J Lipid Res (2001) 0.83
Selective stimulation of a cAMP-specific phosphodiesterase (PDE4A5) isoform by phosphatidic acid molecular species endogenously formed in rat thymocytes. Eur J Biochem (1997) 0.83
Inhibition of the different phosphodiesterase isoforms of rat heart cytosol by free fatty acids. J Cardiovasc Pharmacol (1993) 0.82
Age-related changes in arachidonic acid peroxidation and glutathione-peroxidase activity in human platelets. Prostaglandins (1992) 0.82
Human lymphocytes stimulate prostacyclin synthesis in human umbilical vein endothelial cells. Involvement of endothelial cPLA2. J Leukoc Biol (2000) 0.82
Incorporation and turnover of eicosapentaenoic and docosahexaenoic acids in human blood platelets in vitro. Biochem J (1992) 0.82
Involvement of calcium-independent phospholipase A2 in uterine stromal cell phospholipid remodelling. Eur J Biochem (2000) 0.82
Age-related changes in antioxidant defence mechanisms and peroxidation in isolated hepatocytes from spontaneously hypertensive and normotensive rats. Mol Cell Biochem (1994) 0.82
Docosapentaenoic acid (22:5,n-3): metabolism and effect on prostacyclin production in endothelial cells. Prostaglandins Leukot Essent Fatty Acids (1996) 0.82
Prostaglandin E2-like activity of 20:3n-9 platelet lipoxygenase end-product. FEBS Lett (1985) 0.81
Inhibition of thrombin-induced platelet arachidonic acid release by 15-hydroperoxy-arachidonic acid. Biochem Biophys Res Commun (1981) 0.81
Polyunsaturated fatty acids: drug or food? World Rev Nutr Diet (1984) 0.81
Different metabolic behavior of long-chain n-3 polyunsaturated fatty acids in human platelets. Biochim Biophys Acta (1988) 0.81
Arachidonic acid up-regulates and prostaglandin E2 down-regulates the expression of pancreatic-type phospholipase A2 and prostaglandin-endoperoxide synthase 2 in uterine stromal cells. Eur J Biochem (1996) 0.81
Impaired G-proteins and cyclic nucleotide phosphodiesterase activity in T-lymphocytes from patients with sarcoidosis. Eur J Clin Invest (1993) 0.81
Inhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscle. 14-Hydroxy from 22:6n-3 is more potent than 12-HETE. Biochem Pharmacol (1988) 0.81